P38.alpha. as a therapeutic target in bladder carcinoma

Details P38.alpha. as a therapeutic target in bladder carcinoma P38.alpha. as a therapeutic target in bladder carcinoma

A - Human Necessities

61

K

A61K 31/713 (2006.01) A61K 31/404 (2006.01) A61K 31/4439 (2006.01) A61P 13/10 (2006.01) A61P 35/00 (2006.01) A61K 31/7088 (2006.01) A61K 39/395 (2006.01)

Patent

CA 2686421

The present invention concerns methods and compositions for treating bladder carcinoma by p38 inhibitors.

L'invention porte sur des méthodes et compositions de traitement du carcinome de la vessie par des inhibiteurs p38.

Affiliated with

Also associated with

Rating

P38.alpha. as a therapeutic target in bladder carcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with P38.alpha. as a therapeutic target in bladder carcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P38.alpha. as a therapeutic target in bladder carcinoma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1505385